The Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA) released a statement together on April 12 where they recommended a small pause on administering the Jenssen vaccine.
Even though there’s no evidence that the Johnson & Johnson vaccine caused extremely rare thromboembolic events, it’s still better to be safe than sorry, so this measure was taken out of caution.
Here’s Everything You Need to Know About Johnson & Johnson’s Vaccine. CLICK HERE to read more about this topic!
